DBV1605 for Cow's Milk Allergy

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Cow's Milk AllergyDBV1605 - CombinationProduct
Eligibility
29 - 24
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new method for diagnosing non-IgE mediated cow's milk allergy in children with symptoms suggestive of the allergy.

Eligible Conditions
  • Cow's Milk Allergy

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 72 hours

72 hours
Diagnostic performance of DBV1605
Up to day 49
Adverse Events (AEs), Treatment Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs)

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

2 Treatment Groups

Disease group
1 of 2
Control group
1 of 2

Experimental Treatment

230 Total Participants · 2 Treatment Groups

Primary Treatment: DBV1605 · No Placebo Group · Phase 2

Disease group
CombinationProduct
Experimental Group · 1 Intervention: DBV1605 · Intervention Types: CombinationProduct
Control group
CombinationProduct
Experimental Group · 1 Intervention: DBV1605 · Intervention Types: CombinationProduct

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 72 hours

Who is running the clinical trial?

DBV TechnologiesLead Sponsor
15 Previous Clinical Trials
2,692 Total Patients Enrolled

Eligibility Criteria

Age 29 - 24 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Subjects with clinical symptoms suggestive of non-IgE mediated cow's milk allergy.
Patient has a disease group of a specific type.\n
You are male or female subjects aged > 28 days to ≤ 24 months at Screening Visit.
Subjects with any type of diet containing daily products with cow's milk protein (e.g.

Who else is applying?

What state do they live in?
Florida100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Sunshine Research Center100.0%
What portion of applicants met pre-screening criteria?
Met criteria50.0%
Did not meet criteria50.0%